Enovix (NASDAQ:ENVX) Updates Q1 2026 Earnings Guidance

Enovix (NASDAQ:ENVXGet Free Report) updated its first quarter 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of -0.180–0.140 for the period, compared to the consensus earnings per share estimate of -0.190. The company issued revenue guidance of $6.5 million-$7.5 million, compared to the consensus revenue estimate of $8.8 million.

Enovix Stock Performance

Shares of NASDAQ ENVX traded up $0.04 during midday trading on Wednesday, hitting $6.15. The company’s stock had a trading volume of 7,927,941 shares, compared to its average volume of 6,375,479. Enovix has a 1-year low of $5.27 and a 1-year high of $16.49. The firm’s fifty day moving average price is $7.21 and its 200-day moving average price is $8.98. The company has a debt-to-equity ratio of 1.74, a quick ratio of 9.47 and a current ratio of 9.72. The firm has a market cap of $1.33 billion, a P/E ratio of -7.59 and a beta of 2.13.

Enovix (NASDAQ:ENVXGet Free Report) last released its quarterly earnings data on Wednesday, February 25th. The company reported ($0.14) earnings per share for the quarter, topping the consensus estimate of ($0.17) by $0.03. Enovix had a negative net margin of 525.93% and a negative return on equity of 61.78%. Enovix has set its Q1 2026 guidance at -0.180–0.140 EPS. On average, sell-side analysts forecast that Enovix will post -1.01 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

ENVX has been the topic of several recent research reports. Cantor Fitzgerald cut their price target on Enovix from $30.00 to $25.00 and set an “overweight” rating on the stock in a report on Thursday, November 6th. Oppenheimer set a $24.00 target price on Enovix in a research report on Thursday, November 6th. Northland Securities set a $16.00 target price on Enovix in a research note on Monday, November 17th. Canaccord Genuity Group reduced their price target on shares of Enovix from $22.00 to $21.00 and set a “buy” rating for the company in a report on Thursday, November 6th. Finally, JPMorgan Chase & Co. dropped their price objective on shares of Enovix from $12.00 to $10.00 and set a “neutral” rating on the stock in a report on Wednesday, November 12th. Five analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Enovix has an average rating of “Hold” and a consensus price target of $17.50.

Get Our Latest Stock Report on Enovix

Institutional Investors Weigh In On Enovix

Hedge funds and other institutional investors have recently modified their holdings of the stock. Private Advisor Group LLC grew its position in Enovix by 2.7% in the 3rd quarter. Private Advisor Group LLC now owns 46,519 shares of the company’s stock valued at $464,000 after buying an additional 1,242 shares in the last quarter. Parallel Advisors LLC lifted its stake in shares of Enovix by 51.9% in the 3rd quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock worth $39,000 after acquiring an additional 1,342 shares during the period. Equitable Holdings Inc. lifted its stake in shares of Enovix by 10.9% in the 3rd quarter. Equitable Holdings Inc. now owns 13,700 shares of the company’s stock worth $137,000 after acquiring an additional 1,342 shares during the period. Mariner LLC boosted its holdings in shares of Enovix by 3.4% in the third quarter. Mariner LLC now owns 58,343 shares of the company’s stock valued at $582,000 after acquiring an additional 1,921 shares in the last quarter. Finally, Federation des caisses Desjardins du Quebec increased its stake in shares of Enovix by 2.5% during the fourth quarter. Federation des caisses Desjardins du Quebec now owns 80,853 shares of the company’s stock valued at $591,000 after acquiring an additional 1,950 shares during the period. 50.92% of the stock is currently owned by institutional investors.

Enovix Company Profile

(Get Free Report)

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.

Featured Stories

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.